Cargando…
Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
AIMS: Gp91-containing NADPH oxidases (NOX2) are a significant source of myocardial superoxide production. An increase in NOX2 activity accompanies atrial fibrillation (AF) induction and electrical remodelling in animal models and predicts incident AF in humans; however, a direct causal role for NOX2...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479801/ https://www.ncbi.nlm.nih.gov/pubmed/33483749 http://dx.doi.org/10.1093/cvr/cvab019 |
_version_ | 1784576336986112000 |
---|---|
author | Mighiu, Alexandra S Recalde, Alice Ziberna, Klemen Carnicer, Ricardo Tomek, Jakub Bub, Gil Brewer, Alison C Verheule, Sander Shah, Ajay M Simon, Jillian N Casadei, Barbara |
author_facet | Mighiu, Alexandra S Recalde, Alice Ziberna, Klemen Carnicer, Ricardo Tomek, Jakub Bub, Gil Brewer, Alison C Verheule, Sander Shah, Ajay M Simon, Jillian N Casadei, Barbara |
author_sort | Mighiu, Alexandra S |
collection | PubMed |
description | AIMS: Gp91-containing NADPH oxidases (NOX2) are a significant source of myocardial superoxide production. An increase in NOX2 activity accompanies atrial fibrillation (AF) induction and electrical remodelling in animal models and predicts incident AF in humans; however, a direct causal role for NOX2 in AF has not been demonstrated. Accordingly, we investigated whether myocardial NOX2 overexpression in mice (NOX2-Tg) is sufficient to generate a favourable substrate for AF and further assessed the effects of atorvastatin, an inhibitor of NOX2, on atrial superoxide production and AF susceptibility. METHODS AND RESULTS: NOX2-Tg mice showed a 2- to 2.5-fold higher atrial protein content of NOX2 compared with wild-type (WT) controls, which was associated with a significant (twofold) increase in NADPH-stimulated superoxide production (2-hydroxyethidium by HPLC) in left and right atrial tissue homogenates (P = 0.004 and P = 0.019, respectively). AF susceptibility assessed in vivo by transoesophageal atrial burst stimulation was modestly increased in NOX2-Tg compared with WT (probability of AF induction: 88% vs. 69%, respectively; P = 0.037), in the absence of significant alterations in AF duration, surface ECG parameters, and LV mass or function. Mechanistic studies did not support a role for NOX2 in promoting electrical or structural remodelling, as high-resolution optical mapping of atrial tissues showed no differences in action potential duration and conduction velocity between genotypes. In addition, we did not observe any genotype difference in markers of fibrosis and inflammation, including atrial collagen content and Col1a1, Il-1β, Il-6, and Mcp-1 mRNA. Similarly, NOX2 overexpression did not have consistent effects on RyR2 Ca(2+) leak nor did it affect PKA or CaMKII-mediated RyR2 phosphorylation. Finally, treatment with atorvastatin significantly inhibited atrial superoxide production in NOX2-Tg but had no effect on AF induction in either genotype. CONCLUSION: Together, these data indicate that while atrial NOX2 overexpression may contribute to atrial arrhythmogenesis, NOX2-derived superoxide production does not affect the electrical and structural properties of the atrial myocardium. |
format | Online Article Text |
id | pubmed-8479801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-84798012021-09-30 Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice Mighiu, Alexandra S Recalde, Alice Ziberna, Klemen Carnicer, Ricardo Tomek, Jakub Bub, Gil Brewer, Alison C Verheule, Sander Shah, Ajay M Simon, Jillian N Casadei, Barbara Cardiovasc Res Original Articles AIMS: Gp91-containing NADPH oxidases (NOX2) are a significant source of myocardial superoxide production. An increase in NOX2 activity accompanies atrial fibrillation (AF) induction and electrical remodelling in animal models and predicts incident AF in humans; however, a direct causal role for NOX2 in AF has not been demonstrated. Accordingly, we investigated whether myocardial NOX2 overexpression in mice (NOX2-Tg) is sufficient to generate a favourable substrate for AF and further assessed the effects of atorvastatin, an inhibitor of NOX2, on atrial superoxide production and AF susceptibility. METHODS AND RESULTS: NOX2-Tg mice showed a 2- to 2.5-fold higher atrial protein content of NOX2 compared with wild-type (WT) controls, which was associated with a significant (twofold) increase in NADPH-stimulated superoxide production (2-hydroxyethidium by HPLC) in left and right atrial tissue homogenates (P = 0.004 and P = 0.019, respectively). AF susceptibility assessed in vivo by transoesophageal atrial burst stimulation was modestly increased in NOX2-Tg compared with WT (probability of AF induction: 88% vs. 69%, respectively; P = 0.037), in the absence of significant alterations in AF duration, surface ECG parameters, and LV mass or function. Mechanistic studies did not support a role for NOX2 in promoting electrical or structural remodelling, as high-resolution optical mapping of atrial tissues showed no differences in action potential duration and conduction velocity between genotypes. In addition, we did not observe any genotype difference in markers of fibrosis and inflammation, including atrial collagen content and Col1a1, Il-1β, Il-6, and Mcp-1 mRNA. Similarly, NOX2 overexpression did not have consistent effects on RyR2 Ca(2+) leak nor did it affect PKA or CaMKII-mediated RyR2 phosphorylation. Finally, treatment with atorvastatin significantly inhibited atrial superoxide production in NOX2-Tg but had no effect on AF induction in either genotype. CONCLUSION: Together, these data indicate that while atrial NOX2 overexpression may contribute to atrial arrhythmogenesis, NOX2-derived superoxide production does not affect the electrical and structural properties of the atrial myocardium. Oxford University Press 2021-01-23 /pmc/articles/PMC8479801/ /pubmed/33483749 http://dx.doi.org/10.1093/cvr/cvab019 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Mighiu, Alexandra S Recalde, Alice Ziberna, Klemen Carnicer, Ricardo Tomek, Jakub Bub, Gil Brewer, Alison C Verheule, Sander Shah, Ajay M Simon, Jillian N Casadei, Barbara Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice |
title | Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice |
title_full | Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice |
title_fullStr | Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice |
title_full_unstemmed | Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice |
title_short | Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice |
title_sort | inducibility, but not stability, of atrial fibrillation is increased by nox2 overexpression in mice |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479801/ https://www.ncbi.nlm.nih.gov/pubmed/33483749 http://dx.doi.org/10.1093/cvr/cvab019 |
work_keys_str_mv | AT mighiualexandras inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT recaldealice inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT zibernaklemen inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT carnicerricardo inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT tomekjakub inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT bubgil inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT breweralisonc inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT verheulesander inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT shahajaym inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT simonjilliann inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice AT casadeibarbara inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice |